Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001013594-07-000142
Filing Date
2007-02-16
Accepted
2007-02-16 15:09:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 FEBRUARY 16, 2007 synta13g-021607.htm SC 13G 167360
  Complete submission text file 0001013594-07-000142.txt   169079
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Subject) CIK: 0001157601 (see all company filings)

EIN.: 000000000
Type: SC 13G | Act: 34 | File No.: 005-82674 | Film No.: 07630991
SIC: 2834 Pharmaceutical Preparations

Mailing Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153
Business Address 767 FIFTH AVENUE 19TH FLOOR NEW YORK NY 10153 212-763-8000
Luxor Capital Group, LP (Filed by) CIK: 0001316580 (see all company filings)

EIN.: 201394199 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G